The purpose of this study is to evaluate the long-term safety of an investigational medication in postmenopausal women who have low bone mineral density. Bone mineral density is a measure of the amount of minerals, such as calcium, in a specific volume of bone, which reflects bone strength and health.
Participants in this study will undergo various procedures to monitor their health and the effects of the investigational medication. This may include regular check-ups, bone density scans, and blood tests to ensure safety and gather data on the medication's impact.
- Who can participate: Postmenopausal women aged 50 and older with low bone mineral density are eligible to participate.
- Study details: Participants will receive the investigational medication and attend regular health check-ups. A placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine, may also be used in the study.
